Sugi Predict

Sugi Predict / Compounds / SCHEMBL1010171

SCHEMBL1010171

SCHEMBL1010171

N#Cc1ccc(-c2ccccn2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 1/20 0.56
▸ GRM5 P41594 8/20 0.54
▸ CYP1A2 P05177 2/20 0.50
▸ METAP1 P53582 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ CCR1 P32246 1/20 0.50
▸ CCR5 P51681 1/20 0.50
▸ CCR8 P51685 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ DOHH Q9BU89 1/20 0.50
▸ P4HTM Q9NXG6 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP19A1 P11511 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ METAP2 P50579 1/20 0.49
▸ HSD11B1 P28845 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27652584 1.00 TGFBR1 (0.56) TGFBR1GRM5CYP1A2METAP1KDM4E
SCHEMBL15159901 0.90 ABCG2 (0.50) TGFBR1GRM5HSD11B1MEN1KMT2A
SCHEMBL14073536 0.86 GRM5 (0.50) TGFBR1GRM5METAP1METAP2HSD11B1
SCHEMBL18411444 0.86 GRM5 (0.50) TGFBR1GRM5METAP1METAP2HSD11B1
SCHEMBL19164181 0.86 GRM5 (0.51) TGFBR1GRM5CYP1A2METAP1CYP2D6
SCHEMBL19164678 0.84 FFAR1 (0.48) TGFBR1GRM5CYP1A2METAP1KDM4E
Hydrochloric Acid SCHEMBL11601603 0.84 GRM5 (0.44) TGFBR1GRM5CYP1A2METAP1KDM4E
SCHEMBL16016625 0.83 GRM5 (0.60) GRM5KDM4EGABRA1GABRG2GABRB3
SCHEMBL1566968 0.82 KDM4E (0.72) CYP1A2METAP1KDM4ELMNAPOLB
SCHEMBL30989133 0.82 KDM4E (0.72) CYP1A2METAP1KDM4ELMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113480475-A Synthesis method of 4- (2-pyridyl) benzonitrile 江苏八巨药业有限公司 2021-10-08 — — CN claimed
JP-9216868-A — — None — — JP disclosed
US-20230345811-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-26 — — US disclosed
US-20230209988-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE HAVING THE SAME LG DISPLAY CO., LTD. (KR) 2023-06-29 — — US disclosed
US-20230209988-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE HAVING THE SAME LG DISPLAY CO., LTD. (KR) 2023-06-29 — — US disclosed
US-20220177451-A1 1-CYANO-PYRROLIDINE DERIVATIVES AS DUB INHIBITORS MISSION THERAPEUTICS LIMITED (GB) 2022-06-09 — — US disclosed
US-11352339-B2 1-cyano-pyrrolidine derivatives as DUB inhibitors MISSION THERAPEUTICS LIMITED (GB) 2022-06-07 — — US disclosed
US-20220169581-A1 DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2022-06-02 — — US disclosed
EP-3433246-B1 1-CYANO-PYRROLIDINE DERIVATIVES AS DBU INHIBITORS MISSION THERAPEUTICS LTD (GB) 2022-05-04 — — EP disclosed
CN-111320575-B Pyridine-2-aryl-3-sulfonamide compound and synthesis method and application thereof 浙江大学 2022-04-05 — — CN disclosed
JP-H09216868-A 2-(4-ACYLPHENYL)PYRIDINE AND ITS OXIME SANKYO CO LTD 1997-08-19 — — JP disclosed
EP-0511487-B1 Electro-optical liquid crystal system MERCK PATENT GMBH (DE) 1996-05-29 — — EP disclosed
EP-0700983-A2 Electrooptical liquid crystal system MERCK PATENT GmbH (DE) 1996-03-13 — — EP disclosed
US-5344587-A Nitriles MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1994-09-06 — — US disclosed
EP-0511487-A1 Electro-optical liquid crystal system MERCK PATENT GmbH (DE) 1992-11-04 — — EP disclosed
EP-0500815-A1 LIQUID-CRYSTAL MIXTURE MERCK PATENT GmbH (DE) 1992-09-02 — — EP disclosed
WO-1992004421-A1 LIQUID-CRYSTAL MIXTURE MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1992-03-19 — — WO disclosed
WO-1991005029-A1 ELECTRO-OPTICAL LIQUID CRYSTAL SYSTEM MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-04-18 — — WO disclosed
US-4212978-A Process for the catalytic production of 2-substituted pyridines LONZA LTD. (CH) 1980-07-15 — — US disclosed
US-4196287-A Process for the catalytic production of 2-substituted pyridines LONZA LTD. (CH) 1980-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352339-B2 1-cyano-pyrrolidine derivatives as DUB inhibitors USP30, USP28, USP1 TGFBR1 1422/4885GRM5 3971/4885CYP1A2 537/4885
US-20220169581-A1 DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST PPOX, CYCS, SCO2 TGFBR1 4769/4885GRM5 4255/4885CYP1A2 110/4885
US-20220177451-A1 1-CYANO-PYRROLIDINE DERIVATIVES AS DUB INHIBITORS USP30, USP28, USP1 TGFBR1 1422/4885GRM5 3971/4885CYP1A2 537/4885
US-20230345811-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OPRD1, L1CAM, OPRM1 TGFBR1 1273/4885GRM5 3314/4885CYP1A2 2224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.